Health Trials

Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

ConditionInvasive Fungal Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSichuan Provincial People's Hospital

About this trial

Efficacy and safety of amphotericin B and azoles in the treatment of invasive fungal disease

Eligibility criteria

Qualifiers

There is no age limit, gender is not limited

Patients with invasive fungal disease who are treated with polyene antifungals or azole antifungals should be treated for ≥ 7 days.

Disqualifiers

Patients with incomplete data or other factors affecting the clinical outcome judgement

Patients who are judged by the investigator to be unsuitable to participate in this study.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Sichuan Provincial People's Hospital

Lead sponsor

Source ClinicalTrials.gov